231 results
8-K/A
EX-10.1
GYRE
Gyre Therapeutics Inc
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
EX-10.2
GYRE
Gyre Therapeutics Inc
2 Nov 23
Changes in Registrant's Certifying Accountant
5:00pm
8-K
EX-10.1
GYRE
Gyre Therapeutics Inc
2 Nov 23
Changes in Registrant's Certifying Accountant
5:00pm
8-K
EX-10.4
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.2
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.5
wdzz 0nizn
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.3
lrqeghnpvlorq z1
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.1
oky3ya7li5krn6pb wb8
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-10.1
xcjwqsclhj31h0
2 Mar 23
Catalyst Biosciences Provides Corporate Update
4:16pm
425
EX-10.1
a5aqqj
27 Dec 22
Business combination disclosure
7:02am
8-K
EX-10.1
5zyhstx5mxka
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am
8-K
EX-10.1
hwps42kr
4 Apr 22
Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial
7:18pm
8-K
EX-10.2
b0do8wn815joz
4 Apr 22
Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial
7:18pm